Bolt Biotherapeutics (BOLT) Competitors $0.49 -0.02 (-4.29%) Closing price 02/21/2025 03:58 PM EasternExtended Trading$0.49 0.00 (0.00%) As of 02/21/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrends BOLT vs. FBIO, CRIS, SABS, MTEM, AMGN, VRTX, GILD, REGN, ALNY, and BIIBShould you be buying Bolt Biotherapeutics stock or one of its competitors? The main competitors of Bolt Biotherapeutics include Fortress Biotech (FBIO), Curis (CRIS), SAB Biotherapeutics (SABS), Molecular Templates (MTEM), Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Alnylam Pharmaceuticals (ALNY), and Biogen (BIIB). These companies are all part of the "biotechnology" industry. Bolt Biotherapeutics vs. Fortress Biotech Curis SAB Biotherapeutics Molecular Templates Amgen Vertex Pharmaceuticals Gilead Sciences Regeneron Pharmaceuticals Alnylam Pharmaceuticals Biogen Bolt Biotherapeutics (NASDAQ:BOLT) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, community ranking, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment. Do analysts rate BOLT or FBIO? Bolt Biotherapeutics presently has a consensus target price of $3.50, suggesting a potential upside of 617.21%. Fortress Biotech has a consensus target price of $13.67, suggesting a potential upside of 743.62%. Given Fortress Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Fortress Biotech is more favorable than Bolt Biotherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bolt Biotherapeutics 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in BOLT or FBIO? Fortress Biotech received 247 more outperform votes than Bolt Biotherapeutics when rated by MarketBeat users. However, 64.52% of users gave Bolt Biotherapeutics an outperform vote while only 63.62% of users gave Fortress Biotech an outperform vote. CompanyUnderperformOutperformBolt BiotherapeuticsOutperform Votes8064.52% Underperform Votes4435.48% Fortress BiotechOutperform Votes32763.62% Underperform Votes18736.38% Which has more volatility & risk, BOLT or FBIO? Bolt Biotherapeutics has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Does the media favor BOLT or FBIO? In the previous week, Bolt Biotherapeutics' average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score. Company Overall Sentiment Bolt Biotherapeutics Neutral Fortress Biotech Neutral Is BOLT or FBIO more profitable? Fortress Biotech has a net margin of -84.53% compared to Bolt Biotherapeutics' net margin of -665.56%. Fortress Biotech's return on equity of 0.00% beat Bolt Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Bolt Biotherapeutics-665.56% -69.46% -48.55% Fortress Biotech -84.53%N/A -34.93% Which has better valuation & earnings, BOLT or FBIO? Fortress Biotech has higher revenue and earnings than Bolt Biotherapeutics. Fortress Biotech is trading at a lower price-to-earnings ratio than Bolt Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBolt Biotherapeutics$7.88M2.37-$69.20M-$1.71-0.29Fortress Biotech$84.51M0.53-$60.64M-$3.05-0.53 Do insiders and institutionals believe in BOLT or FBIO? 86.7% of Bolt Biotherapeutics shares are held by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are held by institutional investors. 30.9% of Bolt Biotherapeutics shares are held by company insiders. Comparatively, 33.4% of Fortress Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryFortress Biotech beats Bolt Biotherapeutics on 12 of the 16 factors compared between the two stocks. Get Bolt Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BOLT vs. The Competition Export to ExcelMetricBolt BiotherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.51M$7.06B$5.84B$9.14BDividend YieldN/A2.75%4.75%3.85%P/E Ratio-0.295.7326.0419.11Price / Sales2.37306.03447.4676.36Price / CashN/A65.6738.0134.83Price / Book0.166.717.644.62Net Income-$69.20M$138.33M$3.18B$245.85M7 Day Performance-2.75%-2.63%-2.00%-2.61%1 Month Performance-7.92%-2.33%-0.44%-2.14%1 Year Performance-59.33%-5.33%16.44%12.98% Bolt Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BOLTBolt Biotherapeutics3.1554 of 5 stars$0.49-4.3%$3.50+617.2%-56.8%$19.51M$7.88M-0.2990FBIOFortress Biotech1.8958 of 5 stars$1.75-2.0%$13.67+681.0%-6.4%$48.30M$84.51M-0.57170CRISCuris2.7959 of 5 stars$3.22flat$23.00+614.3%-69.9%$27.27M$10.02M-0.4160Gap UpSABSSAB Biotherapeutics2.3667 of 5 stars$1.68-18.4%$12.40+638.1%-64.8%$15.51M$2.24M0.00140High Trading VolumeMTEMMolecular TemplatesN/A$0.00flatN/A-100.0%$2,000.00$57.31M0.00260Gap UpAMGNAmgen4.4751 of 5 stars$294.79+0.4%$314.09+6.5%+6.9%$158.46B$33.42B39.0526,700Insider TradePositive NewsVRTXVertex Pharmaceuticals4.1169 of 5 stars$469.97+0.1%$502.58+6.9%+15.4%$121.03B$9.87B-236.175,400Analyst DowngradeInsider TradeAnalyst RevisionPositive NewsGILDGilead Sciences4.7947 of 5 stars$95.48-0.6%$98.39+3.0%+50.2%$118.99B$28.30B1,060.8918,000Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive NewsREGNRegeneron Pharmaceuticals4.6674 of 5 stars$690.36-2.8%$973.13+41.0%-26.5%$75.86B$14.20B18.0313,450Dividend AnnouncementALNYAlnylam Pharmaceuticals4.4628 of 5 stars$274.06-0.8%$298.61+9.0%+61.9%$35.35B$2.09B-104.602,100Analyst ForecastInsider TradeBIIBBiogen4.7515 of 5 stars$142.54+0.8%$228.80+60.5%-36.4%$20.77B$9.61B12.887,570Analyst Forecast Related Companies and Tools Related Companies Fortress Biotech Alternatives Curis Alternatives SAB Biotherapeutics Alternatives Molecular Templates Alternatives Amgen Alternatives Vertex Pharmaceuticals Alternatives Gilead Sciences Alternatives Regeneron Pharmaceuticals Alternatives Alnylam Pharmaceuticals Alternatives Biogen Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BOLT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bolt Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BOLT Stock Alerts